首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1672820

抗病毒藥物市場按藥物類別、類型、應用、分銷管道和地區分類

Antiviral Drugs Market, By Drug Class, By Type, By Application, By Distribution Channel, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球抗病毒藥物市場規模為 670.4 億美元，到 2032 年將達到 963 億美元，2025 年至 2032 年的複合年成長率為 5.3%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	670.4億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	5.30%	2032 年金額預測	963億美元

數字。 2025 年抗病毒藥物市場佔有率（按地區分類）

過去幾年，全球抗病毒藥物市場一直穩定成長。抗病毒藥，也稱為抗病毒藥或感染疾病，是一類專門用於治療病毒引起的感染疾病的藥物。抗病毒藥物透過阻止病毒的產生或防止病毒在體內傳播發揮作用。愛滋病毒/愛滋病、肝炎和流感等病毒性疾病的日益流行，正在推動全球對抗病毒藥物的需求。根據世界衛生組織 (WHO) 的數據，2020 年全球約有 3,670 萬人感染愛滋病毒。

市場動態

全球抗病毒藥物市場的成長受到病毒感染疾病和流行病發病率不斷增加的推動。新冠肺炎疫情的出現進一步增加了抗病毒藥物的治療需求。政府的有利支持和醫療設施支出的增加也推動了市場的成長。然而，藥物研發的高成本以及嚴格的監管核准限制了市場擴張。從積極的一面來看，對新型抗病毒治療方法的研究和開發的加強預計將在未來幾年為參與企業創造豐厚的機會。

研究的主要特點

本報告對全球抗病毒藥物市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球抗病毒藥物市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
主要企業包括 AbbVie Inc.、GSK plc、Dr. Reddy's Laboratories Ltd.、F. Hoffmann-La Roche Ltd.、Bristol-Myers Squibb Company、Cipla、Aurobindo Pharma、Gilead Sciences, Inc.、Merck &Cox. 、Arbutus Biopharma、Divi's Laboratories Limited、RedHill Biopharma Ltd.、ViiV Healthcare Pty Ltd. 等。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球抗病毒藥物市場迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過全球抗病毒藥物市場分析中使用的各種策略矩陣來促進決策。

公司簡介
- AbbVie Inc.
- GSK plc
- Dr. Reddy's Laboratories Ltd.
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Cipla
- Aurobindo Pharma
- Gilead Sciences, Inc.
- Merck &Co., Inc.
- Zydus Group
- Atea Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Torrent Pharmaceuticals Ltd.
- Arbutus Biopharma
- Divi's Laboratories Limited
- RedHill Biopharma Ltd.
- ViiV Healthcare Pty Ltd.

第 11 章分析師建議

興衰
一致的機會地圖

第 12 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI4912

Global Antiviral Drugs Market is estimated to be valued at USD 67.04 Bn in 2025 and is expected to reach USD 96.30 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 67.04 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 96.30 Bn

Figure. Antiviral Drugs Market Share (%), By Region 2025

The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by inhibiting the production of viruses or preventing their spread in the body. Rising prevalence of viral diseases such as HIV/AIDS, hepatitis, influenza and others have been fueling demand for antiviral medications globally. According to the World Health Organization (WHO), around 36.7 million people were living with HIV worldwide in 2020.

Market Dynamics:

The global antiviral drugs market growth is driven by the growing incidence of viral infections and pandemics. The emergence of COVID-19 pandemic has further augmented the demand for antiviral drugs for treatment. Favorable government support and rising expenditure on healthcare facilities are also propelling the market growth. However, high costs associated with drug discovery and development as well as stringent regulatory approvals are restraining the market expansion. On the positive side, increasing R&D for developing novel antiviral therapeutics is expected to create lucrative opportunities for players in the coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global antiviral drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global antiviral drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes AbbVie Inc., GSK plc, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Cipla, Aurobindo Pharma, Gilead Sciences, Inc., Merck & Co., Inc., Zydus Group, Atea Pharmaceuticals, Johnson & Johnson Services, Inc., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Torrent Pharmaceuticals Ltd., Arbutus Biopharma, Divi's Laboratories Limited, RedHill Biopharma Ltd., ViiV Healthcare Pty Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global antiviral drugs market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antiviral drugs market.

Detailed Segmentation-

By Drug Class:
- DNA Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Neuraminidase Inhibitors
- Others
By Type:
- Branded
- Generics
By Application:
- HIV
- Hepatitis
- Herpes
- Influenza
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AbbVie Inc.
- GSK plc
- Reddy's Laboratories Ltd.
- Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Cipla
- Aurobindo Pharma
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Zydus Group
- Atea Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Torrent Pharmaceuticals Ltd.
- Arbutus Biopharma
- Divi's Laboratories Limited
- RedHill Biopharma Ltd.
- ViiV Healthcare Pty Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Antiviral Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Antiviral Drugs Market, By Drug Class, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
DNA Polymerase Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Reverse Transcriptase Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Protease Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neuraminidase Inhibitors
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Antiviral Drugs Market, By Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Antiviral Drugs Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
HIV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Herpes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Antiviral Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Antiviral Drugs Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa

10. Competitive Landscape

Company Profiles
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dr. Reddy's Laboratories Ltd.
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Cipla
- Aurobindo Pharma
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Zydus Group
- Atea Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Torrent Pharmaceuticals Ltd.
- Arbutus Biopharma
- Divi's Laboratories Limited
- RedHill Biopharma Ltd.
- ViiV Healthcare Pty Ltd.